Skip to content

R&D at other companies

Illumina logo
IlluminaILMN
$240M-4.8%
Guardant Health logo
Guardant HealthGH
$91.04M+2.8%
Natera, Inc. logo
Natera, Inc.NTRA
$210.7M+63.2%
Personalis, Inc. logo
Personalis, Inc.PSNL
$14.54M+15.0%
Myriad Genetics logo
Myriad GeneticsMYGN
$27.1M-1.5%
Revvity logo
RevvityRVTY
$57.89M+8.0%

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$5.52B+25.7%
Enterprise value$5.13B
P/E186.1×
P/S15.6×

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Return on equity23.5%
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's R&D?
BillionToOne, Inc. (BLLN) reported R&D of $14.69M in Q1 2026.
How has BillionToOne, Inc. 's R&D changed year-over-year?
BillionToOne, Inc. 's R&D increased by 40.9% year-over-year, from $10.43M to $14.69M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.